Oncology Drugs
Delighted to share our latest paper on "Tumor-agnostic drug development in dMMR/MSI-H solid tumors" just published in Trends in Cancer - Vivek Subbiah
Photo taken from Vivek Subbiah/LinkedIn

Delighted to share our latest paper on “Tumor-agnostic drug development in dMMR/MSI-H solid tumors” just published in Trends in Cancer – Vivek Subbiah

Hot off the press! Weekend Reading.

 ➡ Delighted to share our latest paper on “Tumor-agnostic drug development in dMMR/MSI-H solid tumors” just published in Trends in Cancer, Cell Press!

 ➡ dMMR/MSI-H = Perfect marriage of genomics & immunotherapy fields Precision Medicine  

We delve into current drugs, resistance mechanisms, & exciting future developments in this field.

For article: Click here
Source: Vivek Subbiah / Twitter

cancer Drugs immunotherapy OncoDaily Oncology Precision Medicine Research Trends in Cancer Tumor-agnostic tumors Vivek Subbiah